At ESMO 2019, starting on Friday 27 September, promising results will be presented from some studies exploring the use of liquid biopsies in colorectal cancer (CRC), According to Daily Reporter Associate Editor Rodrigo Dienstmann, from Vall d'Hebron University Hospital, Barcelona, Spain, they will show the potential of using ctDNA in deliver precision medicine.
This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.
For more detailed information on the cookies we use, please check our Privacy Policy.
Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.